Evidence map›Paper›PMID 32047434›Full record

ArticleFrontiers in pharmacology2019

Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids.

Melania Maria Serafini, Michele Catanzaro, Francesca Fagiani, Elena Simoni, Roberta Caporaso, Marco Dacrema, Irene Romanoni, Stefano Govoni, Marco Racchi, Maria Daglia and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Frontiers in nutrition · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. 8-WeekAntioxidants (Basel, Switzerland) · 2024
    Article
  17. Review
  18. Combined effects ofFrontiers in nutrition · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Melania Maria SerafiniDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
Michele CatanzaroDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
Francesca FagianiDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
Elena SimoniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Roberta CaporasoDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Marco DacremaDepartment of Pharmacy, University of Napoli Federico II, Naples, Italy.
Irene RomanoniDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
Stefano GovoniDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
Marco RacchiDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
Maria DagliaDepartment of Pharmacy, University of Napoli Federico II, Naples, Italy.
Michela RosiniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Cristina LanniDepartment of Drug Sciences, University of Pavia, Pavia, Italy.
University of Pavia · ITUniversity of Bologna · ITUniversity of Naples Federico II · ITIstituto Universitario di Studi Superiori di Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nrf2 is a basic leucine zipper transcription factor that binds to the promoter region of the antioxidant response element (ARE), inducing the coordinated up-regulation of antioxidant and detoxification genes. We recently synthesized a set of new molecules by combining the functional moieties of curcumin and diallyl sulfide, both known to induce the expression of antioxidant phase II enzymes by activating Nrf2 pathway. The aim of the study is to investigate the ability of such compounds to activate Keap1/Nrf2/ARE cytoprotective pathway, in comparison with two reference Nrf2-activators: curcumin and dimethyl fumarate, a drug approved for the treatment of relapsing-remitting multiple sclerosis. Furthermore, since Nrf2 pathway is known to be regulated also by epigenetic modifications, including key modifications in microRNA (miRNA) expression, the effects of the hybrids on the expression levels of selected miRNAs, associated with Nrf2 signaling pathway have also been investigated. The results show that compounds exert antioxidant effect by activating Nrf2 signaling pathway and inducing the ARE-regulated expression of its downstream target genes, such as HO-1 and NQO1, with two hybrids to a higher extent than curcumin. In addition, some molecules induce changes in the expression levels of miR-125b-5p, even if to a lesser extent than curcumin. However, no changes have been observed in the expression levels of mRNA coding for glutathione synthetase, suggesting that the modulation of this mRNA is not strictly under the control of miR-125b-5p, which could be influenced by other miRNAs.

Indexed as

curcumindimethyl fumarateHO-1Keap1miRNAsNQO1Nrf2

Identifiers

PMID32047434
PMCPMC6997134
OpenAlexW3003766586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.